Related Experiment Video
Updated: Sep 26, 2025
08:32
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
521
Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal Products
Brigitte Anliker1, Liam Childs2, Juliane Rau1
1Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany.
The CRISPR Journal
|April 22, 2022
Summary
CRISPR gene editing technology shows promise for treating genetic diseases. Regulatory frameworks are adapting to ensure the safety and efficacy of these advanced therapies in clinical trials.
Area of Science:
- Biotechnology
- Genetics
- Regulatory Science
Background:
- CRISPR technology offers novel gene targeting and genome editing capabilities.
- CRISPR-Cas9 applications are progressing towards clinical use for genetic diseases.
- Developing CRISPR-based therapeutics necessitates robust regulatory oversight.
Purpose of the Study:
- To outline the current regulatory landscape for CRISPR-Cas developments as advanced therapy medicinal products.
- To identify key scientific and regulatory considerations for advancing CRISPR products into clinical trials in Germany.
- To ensure the safety and efficacy of innovative CRISPR-based medicinal products.
Main Methods:
- Review of the current regulatory framework for advanced therapy medicinal products.
- Discussion of scientific and regulatory requirements for product development.
- Analysis of quality, nonclinical, and clinical development aspects for CRISPR technology.
Main Results:
- CRISPR technology is advancing rapidly into clinical applications.
- Regulatory frameworks are being adapted to accommodate CRISPR-based therapies.
- Key considerations for quality, nonclinical, and clinical development are identified.
Conclusions:
- CRISPR-Cas-based therapies hold significant potential for treating genetic diseases.
- Adaptation of regulatory requirements is crucial for safe and effective clinical translation.
- Germany's regulatory considerations provide a model for advancing CRISPR product development.
Related Concept Videos
01:59CRISPR
53.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.1K
01:11Clinical Trials: Overview
3.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.5K
01:28Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
00:49What is Genetic Engineering?
75.8K
Overview
75.8K
01:16Clinical Trials
9.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.4K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
185
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
185